Great Point Partners’s Momenta Pharmaceuticals MNTA Stock Holding History
Bought
Maintained
Sold
Other funds holding MNTA
Great Point Partners's MNTA Position: Q2 2020 in Review
Great Point Partners sold out of Momenta Pharmaceuticals (MNTA) in Q2 2020, closing a stake of 979,400 shares — an estimated $26.6M sold.
Great Point Partners first reported a position in MNTA in Q1 2014 and held it in 6 quarters. The position peaked at $55.1M in Q4 2019. 238 funds tracked by Wall St. Rank hold MNTA as of Q2 2020.
- Great Point Partners reported no remaining Momenta Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
- Great Point Partners sold 979,400 Momenta Pharmaceuticals shares in Q2 2020, an estimated $26.6M.
- Great Point Partners first reported a position in Momenta Pharmaceuticals in Q1 2014 and held it in 6 quarters.
- Great Point Partners's Momenta Pharmaceuticals position peaked at $55.1M in Q4 2019.
- 238 funds tracked by Wall St. Rank held Momenta Pharmaceuticals as of Q2 2020.
Based on Great Point Partners's 13F filing for Q2 2020, filed 14 Aug 2020.